Curative Efficacy of Hepatocyte Growth-promoting Factors plus Wuji Baifeng Pills for Liver Cirrhosis:Observation of 65 Cases / 中国药房
China Pharmacy
; (12)2007.
Article
en Zh
| WPRIM
| ID: wpr-533282
Biblioteca responsable:
WPRO
ABSTRACT
OBJECTIVE:To observe the clinical efficacy of Hepatocyte growth-promoting factors(PHGF) combined with Wuji baifeng pills for liver cirrhosis. METHODS:A total of 97 patients with liver cirrhosis were randomly assigned to either control group(n=32,conventional therapy) or treatment group(n=65,PHGF plus Wuji baifeng pills in addition to routine treatment).The course of treatment was 3 months for both groups. Clinical data including cardinal symptoms and signs,hepatic function,blood clotting function,hepatic fibrosis parameters,the inner-diameter of the portal vein and splenic vein(PVD,SVD),spleen thickness(SPT) measured by the color Doppler ultrasonography were monitored before and after treatment. RESULTS:After treatment,the symptoms and signs of the treatment group had better improvement than in the control group,with a markedly higher total effective rate than in the control group(84.62% vs.59.38%,P
Texto completo:
1
Base de datos:
WPRIM
Idioma:
Zh
Revista:
China Pharmacy
Año:
2007
Tipo del documento:
Article